HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

QYUNS-B

28.580

+0.0800.28%

Volume:808.80K

Turnover:23.27M

Market Cap:6.49B

PE:-17.15

High:29.680

Open:28.520

Low:27.300

Close:28.500

52wk High:36.500

52wk Low:5.950

Shares:227.07M

HK Float Shares:227.07M

Volume Ratio:0.96

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.666

ROE:-68.26%

ROA:-10.67%

PB:26.31

PE(LYR):-17.15

PS:18.59

Loading ...

Overview Company News Filings

HK Movers | Biomedical Stocks Surge With TransThera Sciences up 42%

Tiger Newspress

Qyuns Therapeutics Unit Passes EU Qualified Person Audit; Shares Down 8%

MT Newswires Live

QYUNS-B (02509): Subsidiary Successfully Passes EU Qualified Person Audit for Manufacturing Base

Qyuns Therapeutics Industrialization Base Passes EU QP Audit Meeting EU GMP Standards

Qyuns Therapeutics (SEHK:2509): Evaluating Valuation After Recent Stock Surge

Simply Wall St.

Tianfeng Securities Initiates Coverage on QYUNS-B (02509) with "Buy" Rating, Target Price HK$40.25

Hong Kong Pharmaceuticals Rise as Trump Drug Tariffs Show Limited Impact; Q4 BD Events Expected

Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 10% Again as Mature Pipeline Enters Monetization Phase, Seleixin Market Sales Accelerating

Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 7% Intraday as Company Accelerates Pipeline Market Potential Realization with Bispecific Antibody Programs Targeting International Markets

Qyuns Therapeutics Raises HK$100 Million via Share Placement; Shares Rise 3%

MT Newswires Live

QYUNS-B (02509) Completes Placement of 5 Million Shares

Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 13% Again Following Strong H1 Performance and Major Investment from TruMed Fund

From Monoclonal to Bispecific Antibodies, From Domestic to Global: How QYUNS-B (02509) Becomes a New Benchmark in the Autoimmune Track?

Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 22% as H1 Revenue Soars with Significant Loss Reduction, Core Product R&D Progresses Smoothly

Qyuns Therapeutics' H1 Loss Narrows; Shares Rise 6%

MT Newswires Live

BRIEF-Qyuns Therapeutics Says To Issue 5 Million Placing Shares At HK$20.0 Per Share

QYUNS-B (02509) Plans to Place 5 Million Shares at Approximately 10.95% Discount, Raising Net Proceeds of About HK$99 Million

Qyuns Therapeutics - to Issue 5 Mln Placing Shares at HK$20.0 per Share

THOMSON REUTERS

QYUNS-B (02509) Announces Interim Results with Revenue of RMB 206 Million, Up 359.69% YoY

BRIEF-Qyuns Therapeutics HY Revenue RMB206.5 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02509/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":28.58,"timestamp":1760688489143,"preClose":28.5,"halted":0,"volume":808800,"delay":0,"floatShares":227071600,"shares":227071600,"eps":-1.666177694921705,"marketStatus":"Closed","change":0.08,"latestTime":"10-17 16:08:09","open":28.52,"high":29.68,"low":27.3,"amount":23266440,"amplitude":0.083509,"askPrice":28.58,"askSize":400,"bidPrice":28.38,"bidSize":9800,"shortable":0,"etf":0,"ttmEps":-0.9409177781644193,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1760923800000},"marketStatusCode":5,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":28.5,"openAndCloseTimeList":[[1760664600000,1760673600000],[1760677200000,1760688000000]],"volumeRatio":0.956309,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":227071600,"roa":"-10.67%","roe":"-68.26%","lyrEps":-1.666178,"volumeRatio":0.956309,"shares":227071600,"dividePrice":0,"high":29.68,"amplitude":0.083509,"preClose":28.5,"low":27.3,"week52Low":5.95,"pbRate":"26.31","psRate":"18.59","week52High":36.5,"institutionHeld":0,"latestPrice":28.58,"committee":0.921569,"eps":-1.666177694921705,"divideRate":0,"volume":808800,"delay":0,"ttmEps":-0.9409177781644193,"open":28.52,"prevYearClose":7.38,"prevWeekClose":29.38,"prevMonthClose":34.88,"prevQuarterClose":34.88,"fiveDayClose":29.38,"twentyDayClose":31.04,"sixtyDayClose":18.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post Market","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2025-10-16","current":-30.369697,"percent":0.05168,"low":-38.274716,"twenty":-11.527301,"median":-9.036913,"eighty":-5.038141,"high":-3.10587,"avg":-10.430096,"sd":7.754113,"marketCap":6471540600},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-16","current":-30.935833,"twenty":-11.527301,"median":-9.036913,"eighty":-5.038141,"marketCap":6471540600}],"updateTime":1760705027356},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1100196411","title":"HK Movers | Biomedical Stocks Surge With TransThera Sciences up 42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100196411","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100196411?lang=en_us&edition=fundamental","pubTime":"2025-10-16 10:54","pubTimestamp":1760583262,"startTime":"0","endTime":"0","summary":"Biomedical stocks surged in Hong Kong. TransThera Sciences rose 42%; 3SBio, Qyuns Therapeutics, and Henlius Biotech rose 9%; Duality Biotherapeutics rose 5%; WuXi Biologics rose 3%; WuXi AppTec rose 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","02359","02696","09606","02617","02509","01530"],"gpt_icon":0},{"id":"2575642167","title":"Qyuns Therapeutics Unit Passes EU Qualified Person Audit; Shares Down 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575642167","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575642167?lang=en_us&edition=fundamental","pubTime":"2025-10-13 13:35","pubTimestamp":1760333702,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  said its unit Jiangsu Cellularforce Biopharma has successfully passed the EU Qualified Person audit, confirming that its industrialization base meets European Union Good Manufacturing Practice standards, according to an Oct. 10 Hong Kong bourse filing.Shares of the firm were down over 8% in Monday afternoon trade.The audit, conducted over three days by a senior EU QP under EudraLex Volume 4 guidelines, recognized the unit's high-quality management system, advanced facilities, and technical capabilities.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","LENZ","BK4539","BK1161","02509","BK4156"],"gpt_icon":0},{"id":"1122486676","title":"QYUNS-B (02509): Subsidiary Successfully Passes EU Qualified Person Audit for Manufacturing Base","url":"https://stock-news.laohu8.com/highlight/detail?id=1122486676","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122486676?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:28","pubTimestamp":1760092097,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that its subsidiary, Jiangsu Saifusi Biotechnology Co., Ltd. (\"Saifusi\"), has successfully passed the European Union Qualified Person (QP) audit and officially received a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","FSXEmain","BK1161","FESXmain"],"gpt_icon":0},{"id":"2574122909","title":"Qyuns Therapeutics Industrialization Base Passes EU QP Audit Meeting EU GMP Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2574122909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574122909?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:19","pubTimestamp":1760091566,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co. Ltd. has announced that its subsidiary, Jiangsu Cellularforce Biopharma Co., Ltd., has successfully passed the EU Qualified Person  audit and received the official compliance audit report. This achievement confirms that the company's industrialization base meets EU Good Manufacturing Practice  standards for pharmaceuticals. The audit, conducted by a senior QP in accordance with EudraLex Volume 4 and related guidelines, recognized Cellularforce's high-standard quality management system, advanced facilities, and professional capabilities. This milestone supports the company's efforts in providing globally compliant biologics CDMO services. No grant or funding involving multiple organizations was mentioned in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL8TWJGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2572868850","title":"Qyuns Therapeutics (SEHK:2509): Evaluating Valuation After Recent Stock Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2572868850","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572868850?lang=en_us&edition=fundamental","pubTime":"2025-10-03 16:27","pubTimestamp":1759480046,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics (SEHK:2509) has caught some attention lately as its stock price climbed over 1% in a day and surged nearly 21% in the past week. Investors are watching these moves closely, considering what they could signal for the company’s current valuation.\nSee our latest analysis for Qyuns Therapeutics.\nThe recent upswing in Qyuns Therapeutics’ share price comes after a string of modest but persistent gains over the past year. While the 1-year total shareholder return is just 0.5%, the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/qyuns-therapeutics-sehk2509-evaluating-valuation-after-recen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/qyuns-therapeutics-sehk2509-evaluating-valuation-after-recen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4539","BK4139","LENZ","BK1161","02509"],"gpt_icon":0},{"id":"1125679907","title":"Tianfeng Securities Initiates Coverage on QYUNS-B (02509) with \"Buy\" Rating, Target Price HK$40.25","url":"https://stock-news.laohu8.com/highlight/detail?id=1125679907","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125679907?lang=en_us&edition=fundamental","pubTime":"2025-09-30 11:02","pubTimestamp":1759201354,"startTime":"0","endTime":"0","summary":"Tianfeng Securities has initiated coverage on QYUNS-B (02509) with a \"Buy\" rating, projecting the company's revenue for 2025-2027 at RMB 3.22/4.41/5.93 billion respectively. The firm assigns a 26x PS...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601162","02509","BK1161","BK0276"],"gpt_icon":0},{"id":"1141949628","title":"Hong Kong Pharmaceuticals Rise as Trump Drug Tariffs Show Limited Impact; Q4 BD Events Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=1141949628","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141949628?lang=en_us&edition=fundamental","pubTime":"2025-09-29 14:48","pubTimestamp":1759128513,"startTime":"0","endTime":"0","summary":"Most pharmaceutical stocks gained strength in Hong Kong trading. As of press time, IMMUNEONCO-B (01541) surged 18.98% to HK$13.48; QYUNS-B (02509) climbed 12.11% to HK$32.96; XTALPI (02228) advanced...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3452d085f48a0e569f128ec4585d109f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1574","HSCEI","159938","01167","LU2328871848.SGD","07226","BK1161","09939","BK1617","LU1969619763.USD","09995","01541","BK1583","BK4614","BK1515","02509","02228","YANG"],"gpt_icon":0},{"id":"1107739457","title":"Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 10% Again as Mature Pipeline Enters Monetization Phase, Seleixin Market Sales Accelerating","url":"https://stock-news.laohu8.com/highlight/detail?id=1107739457","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107739457?lang=en_us&edition=fundamental","pubTime":"2025-09-08 10:28","pubTimestamp":1757298504,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) surged over 10% again, rising 9.64% to HK$27.74 as of press time, with trading volume reaching HK$18.69 million. On the news front, QYUNS-B previously announced its first half 2025...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0049112450.USD","02509","LU1046422090.SGD","BK4531","BK1161","LU1235295612.USD","BK4166","LX","BK4579"],"gpt_icon":0},{"id":"1140944703","title":"Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 7% Intraday as Company Accelerates Pipeline Market Potential Realization with Bispecific Antibody Programs Targeting International Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1140944703","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140944703?lang=en_us&edition=fundamental","pubTime":"2025-09-05 11:32","pubTimestamp":1757043164,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) surged over 7% during trading, and as of press time, the stock was up 6.13% to HK$24.94 with a turnover of HK$12.21 million. On the news front, QYUNS-B's interim results showed that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2562078551","title":"Qyuns Therapeutics Raises HK$100 Million via Share Placement; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562078551","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562078551?lang=en_us&edition=fundamental","pubTime":"2025-08-26 16:17","pubTimestamp":1756196229,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  said it has completed a HK$100 million share placement to TruMed Health Innovation Fund, according to a Monday Hong Kong bourse filing.Shares of the biopharmaceutical firm gained over 3% in afternoon trading on Tuesday.It issued 5 million new H-shares at HK$20 each, representing about 2.2% of its enlarged share capital.Proceeds will be used mainly to repay debt, with a portion earmarked for advancing its drug pipeline, Qyuns said.The company confirmed its public float remains above 25% after the issuance.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","02509","BK4539","BK4007","BK1161"],"gpt_icon":0},{"id":"1153314071","title":"QYUNS-B (02509) Completes Placement of 5 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1153314071","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153314071?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:36","pubTimestamp":1756128986,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that all conditions under the placement agreement have been fulfilled, and the placement was completed in accordance with the terms of the placement agreement on August 25,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1199400602","title":"Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 13% Again Following Strong H1 Performance and Major Investment from TruMed Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1199400602","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199400602?lang=en_us&edition=fundamental","pubTime":"2025-08-21 15:46","pubTimestamp":1755762402,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) surged over 13% again, bringing its year-to-date gains to nearly 300%. As of press time, the stock was up 9.26% to HK$27.6, with turnover of HK$45.4 million. On the news front,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1100623558","title":"From Monoclonal to Bispecific Antibodies, From Domestic to Global: How QYUNS-B (02509) Becomes a New Benchmark in the Autoimmune Track?","url":"https://stock-news.laohu8.com/highlight/detail?id=1100623558","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100623558?lang=en_us&edition=fundamental","pubTime":"2025-08-20 10:55","pubTimestamp":1755658500,"startTime":"0","endTime":"0","summary":"The autoimmune sector is emerging as one of the hottest tracks for innovative drug investment, with synchronized warming in both primary and secondary market transactions. Latest statistics show that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1128317238","title":"Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 22% as H1 Revenue Soars with Significant Loss Reduction, Core Product R&D Progresses Smoothly","url":"https://stock-news.laohu8.com/highlight/detail?id=1128317238","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128317238?lang=en_us&edition=fundamental","pubTime":"2025-08-18 17:57","pubTimestamp":1755511042,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) extended its afternoon gains by over 22%, hitting a high of HK$27.7, marking its highest level since September last year. As of press time, the stock was up 22.08% to HK$27.42, with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2560979859","title":"Qyuns Therapeutics' H1 Loss Narrows; Shares Rise 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560979859","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560979859?lang=en_us&edition=fundamental","pubTime":"2025-08-18 12:01","pubTimestamp":1755489689,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  reported 28.3 million yuan in attributable loss for the half ended June 30, narrowing from a loss of 172.1 million yuan in the year-ago period, according to a Hong Kong bourse filing Friday.Loss per share was 0.13 yuan, compared with 0.79 yuan in the prior year.Revenue rose to 206.5 million yuan from 44.9 million yuan a year earlier, results showed.Shares of the biopharmaceutical company jumped over 6% in morning trade Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK1161","BK4007","LENZ","BK4139","02509"],"gpt_icon":0},{"id":"2560973179","title":"BRIEF-Qyuns Therapeutics Says To Issue 5 Million Placing Shares At HK$20.0 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560973179","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560973179?lang=en_us&edition=fundamental","pubTime":"2025-08-18 09:15","pubTimestamp":1755479732,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Says To Issue 5 Million Placing Shares At HK$20.0 Per ShareAug 18 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:TO ISSUE 5 MILLION PLACING SHARES AT HK$20.0 PER SHAREFurther company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3U8069:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1139654681","title":"QYUNS-B (02509) Plans to Place 5 Million Shares at Approximately 10.95% Discount, Raising Net Proceeds of About HK$99 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1139654681","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139654681?lang=en_us&edition=fundamental","pubTime":"2025-08-18 08:00","pubTimestamp":1755475220,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on August 18, 2025 (before trading hours), the company entered into a placement agreement with a placing agent. Under the agreement, the placing agent has conditionally...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2560611978","title":"Qyuns Therapeutics - to Issue 5 Mln Placing Shares at HK$20.0 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560611978","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560611978?lang=en_us&edition=fundamental","pubTime":"2025-08-18 07:47","pubTimestamp":1755474452,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250817:nFWN3U8069:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1124610552","title":"QYUNS-B (02509) Announces Interim Results with Revenue of RMB 206 Million, Up 359.69% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1124610552","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124610552?lang=en_us&edition=fundamental","pubTime":"2025-08-15 22:08","pubTimestamp":1755266902,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced its results for the six months ended June 30, 2025. The group achieved revenue of RMB 206 million, representing a year-on-year increase of 359.69%. R&D expenses totaled RMB...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2559914912","title":"BRIEF-Qyuns Therapeutics HY Revenue RMB206.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559914912","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559914912?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:45","pubTimestamp":1755265526,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics HY Revenue RMB206.5 MillionAug 15 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:HY REVENUE RMB206.5 MILLIONHY LOSS RMB30.9 MILLION VERSUS LOSS OF RMB183.1 MILLIONFurther company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U61DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}